88IV - PR Newswire Asia's news


Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , March 30, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-03-30T Agriculture Banking/Financial Service Biotechnology
Tigermed Announces 2025 Annual Results HANGZHOU, China , March 30, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery" Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques Hands-on experience with Korean spine medical devices lays the ... 2026-03-30T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
CELEBRATING 25 YEARS AND BEYOND OF LIFE AFTER ORGAN TRANSPLANTATION AT THE NATIONAL UNIVERSITY CENTRE FOR ORGAN TRANSPLANTATION Honouring 35 patients who stand as inspiring examples of resilience, underscoring the long-term success of organ transplantation ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year SHANGHAI , March 30, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Qyuns Therapeutics-B (02509) 2025 Revenue Surges Over 4-Fold; Adjusted Profit Reaches Approximately RMB356 Million, Turning a Profit Year-on-Year TAIZHOU, China , March 30, 2026 /PRNewswire/ -- Qyuns Therapeutics-B (02509) announced its 2025 annual results. Revenue amounted to approximately RMB807 million, representing a 4.08-fold year-on-year ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met AUCKLAND, New Zealand , March 30, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Announces Global R&D Collaboration with Lilly AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. ... 2026-03-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2 TAIPEI , March 28, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and ... 2026-03-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology